XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $118K invested in XTL Biopharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$27K |
| 2 |
2
Morgan Stanley
New York
|
$22K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$7K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $62K | 25,961 | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $27K | 11,551 | +11,551 | New |
|
|
3
Morgan Stanley
New York
| $22K | 9,160 | +2,500 | +38% |
|
|
4
UBS Group
Zurich,
Switzerland
| $7K | 3,040 | -13,269 | -81% |
|